Zymes LLC Obtains GRAS Status For Its New Water-Soluble Coenzyme Q10, HQO(TM)

The U.S. Food and Drug
Administration (FDA) has acknowledged that Zymes' PTS technology is
Generally Recognized as Safe (GRAS) as a solubilizer for coenzyme Q10. PTS
is the lead compound of Ubisol-Aqua(TM), Zymes' delivery system technology.
Ubisol-Aqua(TM) provides superior platforms for solubilizing coenzyme Q10
and other water-insoluble compounds for foods, beverages, nutritional
supplements and pharmaceuticals. Zymes' new water-soluble formulation of
coenzyme Q10, HQO(TM), is a major breakthrough for the many industries
looking to supplement their products with coenzyme Q10.



Zymes' new HQO(TM) has an average particle size in water of 22
nanometers, 10 times smaller than those commercially available. It offers
improved solubility, enhanced bioavailability, higher concentration and is
available for licensing.



"Obtaining GRAS status for our water-soluble coenzyme Q10, HQO(TM),
creates unlimited opportunities in food, beverage and nutritional markets
around the world," said Benjamin D. Mamola, Co-founder and Executive Vice
President of Global Business Development at Zymes. "Our new breakthrough
technology finally makes it possible to deliver coenzyme Q10 in everyday
products like water, soft drinks, juices and many other types of foods,
beverages and nutritional supplements."



Zymes also offers its delivery system technology, Ubisol-Aqua(TM) to
industry partners seeking more efficient ways of making their insoluble or
lipophilic ingredients water-soluble.



"The scientific data presented within our GRAS application indicates
that PTS can safely provide solubility benefits," said Randi Fain, MD,
Co-founder and Executive Vice President of Clinical and Scientific Affairs.
"Receiving the FDA's positive response to our GRAS application is very
important to our research efforts and validates the delivery system's
14-year development process."



About Zymes:


Zymes LLC is a bio-science company that combines science,
technology and nature to create products that improve the quality of life.
It is dedicated to contributing to the well-being of individuals by
developing high-quality products that provide significant,
clinically-proven health and beauty benefits to consumers. Based in
Hasbrouck Heights, NJ, Zymes holds substantial intellectual property
ranging from production of CoQ10 to pharmaceutical drug delivery systems.
For more information, visit zymesllc.


Zymes LLC

zymesllc